Literature DB >> 1588425

The symptomatic and functional outcome of stereotactic thalamotomy for medically intractable essential tremor.

M S Goldman1, J E Ahlskog, P J Kelly.   

Abstract

Eight patients with medically refractory disabling essential tremor underwent ventralis lateralis (VL) thalamotomies; the procedure was unilateral in seven cases and bilateral (staged) in the other. Contralateral tremor remained absent or markedly reduced in all patients at the time of the most recent follow-up examinations, at a mean of 17.3 months after surgery. Disability was determined by a modified form of an established rating scale for tremor, and was reduced from a mean score of 21.1 (moderate grade) to 3.9 (absent grade) (p less than 0.001). Interestingly, voice tremor was abolished or significantly improved in 71.4% of patients with preoperative voice tremor. This feature has not been reported previously. Persistent surgical morbidity was limited to two patients with mild dysarthria and one with a mild cognitive impairment. There were no surgically related deaths. It is concluded that stereotactic VL thalamotomy is a treatment option for medically intractable disabling essential tremor.

Entities:  

Mesh:

Year:  1992        PMID: 1588425     DOI: 10.3171/jns.1992.76.6.0924

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  11 in total

1.  Bilateral high-frequency electrical impulses to the thalamus reduce voice tremor: acoustic and electroglottographic analysis. A case report.

Authors:  Jean Richard Moringlane; Manfred Pützer; William J Barry
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-10-24       Impact factor: 2.503

2.  Therapeutic Stroke - an Interesting Case of Ischemic Stroke in Bilateral Thalamic and Subthalamic Regions Resulting in Reduction of Essential Tremor.

Authors:  Pradeep C Bollu; Chintan Rupareliya
Journal:  Cureus       Date:  2017-10-16

3.  Probabilistic conversion of neurosurgical DBS electrode coordinates into MNI space.

Authors:  Andreas Horn; Andrea A Kühn; Angela Merkl; Ludy Shih; Ron Alterman; Michael Fox
Journal:  Neuroimage       Date:  2017-02-03       Impact factor: 6.556

4.  Deep brain stimulation in essential tremor: targets, technology, and a comprehensive review of clinical outcomes.

Authors:  Joshua K Wong; Christopher W Hess; Leonardo Almeida; Erik H Middlebrooks; Evangelos A Christou; Erin E Patrick; Aparna Wagle Shukla; Kelly D Foote; Michael S Okun
Journal:  Expert Rev Neurother       Date:  2020-03-02       Impact factor: 4.618

Review 5.  Magnetic Resonance-Guided Focused Ultrasound Neurosurgery for Essential Tremor: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2018-05-03

6.  Moving forward: advances in the treatment of movement disorders with deep brain stimulation.

Authors:  Terry K Schiefer; Joseph Y Matsumoto; Kendall H Lee
Journal:  Front Integr Neurosci       Date:  2011-11-09

7.  Incisionless transcranial MR-guided focused ultrasound in essential tremor: cerebellothalamic tractotomy.

Authors:  Marc N Gallay; David Moser; Franziska Rossi; Payam Pourtehrani; Anouk E Magara; Milek Kowalski; Alexander Arnold; Daniel Jeanmonod
Journal:  J Ther Ultrasound       Date:  2016-02-13

8.  Physiological mechanisms of thalamic ventral intermediate nucleus stimulation for tremor suppression.

Authors:  Luka Milosevic; Suneil K Kalia; Mojgan Hodaie; Andres M Lozano; Milos R Popovic; William D Hutchison
Journal:  Brain       Date:  2018-07-01       Impact factor: 13.501

9.  Metabolic alterations in Parkinson's disease after thalamotomy, as revealed by 1H MR spectroscopy.

Authors:  Hyun-Man Baik; Bo-Young Choe; Hyoung-Koo Lee; Tae-Suk Suh; Byung-Chul Son; Jae-Mun Lee
Journal:  Korean J Radiol       Date:  2002 Jul-Sep       Impact factor: 3.500

Review 10.  Outcomes from stereotactic surgery for essential tremor.

Authors:  Robert Francis Dallapiazza; Darrin J Lee; Philippe De Vloo; Anton Fomenko; Clement Hamani; Mojgan Hodaie; Suneil K Kalia; Alfonso Fasano; Andres M Lozano
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-10-18       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.